• Antithrombotic Treatment Patterns And Stroke Prevention In Patients With Atrial Fibrillation In Turkey: Inferences From Garfield-Af Registry 

      Sayın, Begüm Yetiş; Okutucu, Sercan; Yılmaz, Mehmet Birhan; Özdemir, Kurtuluş; Aydınlar, Ali; Şahin, Durmuş Yıldıray; Altun, Armağan; Açıkel, Sadık; Okuyan, Ertuğrul; Sucu, Murat; Öngen, Zeki; Ersanlı, Murat Kazım; Yılmaz, Özcan; Demir, Mesut; Pekdemir, Hasan; Topsakal, Ramazan; Şahiner, Mehmet Levent; Aras, Dursun; Oto, Ali (2019)
      Objective: The corner stone of atrial fibrillation therapy includes the prevention of stroke with less adverse effects. The Global Anticoagulant Registry in the FIELD–Atrial Fibrillation (GARFIELD-AF) study provided data ...
    • Heart Failure In Cardiomyopathies: A Position Paper From The Heart Failure Association Of The European Society Of Cardiology 

      Seferovic, Petar M.; Polovina, Marija; Bauersachs, Johann; Arad, Michael; Ben Gal, Tuvia; Lund, Lars H.; Felix, Stephan B.; Arbustini, Eloisa; Caforio, Alida L. P.; Farmakis, Dimitrios; Filippatos, Gerasimos S.; Gialafos, Elias; Kanjuh, Vladimir; Krljanac, Gordana; Limongelli, Giuseppe; Linhart, Ales; Lyon, Alexander R.; Maksimovic, Ruzica; Milicic, Davor; Milinkovic, Ivan; Noutsias, Michel; Oto, Ali; Oto, Oztekin; Pavlovic, Sinisa U.; Piepoli, Massimo F.; Ristic, Arsen D.; Rosano, Giuseppe M. C.; Seggewiss, Hubert; Asanin, Milika; Seferovic, Jelena R.; Ruschitzka, Frank; Celutkiene, Jelena; Jaarsma, Tiny; Mueller, Christian; Moura, Brenda; Hill, Loreena; Volterrani, Maurizio; Lopatin, Yuri; Metra, Marco; Backs, Johannes; Mullens, Wilfried; Chioncel, Ovidiu; de Boer, Rudolf A.; Anker, Stefan; Rapezzi, Claudio; Coats, Andrew J. s; Tschoepes, Carsten (2019)
      Cardiomyopathies are a heterogeneous group of heart muscle diseases and an important cause of heart failure (HF). Current knowledge on incidence, pathophysiology and natural history of HF in cardiomyopathies is limited, ...
    • Impact Of Diabetes Mellitus And Chronic Kidney Disease On Cardiovascular Outcomes And Platelet P2Y(12) Receptor Antagonist Effects In Patients With Acute Coronary Syndromes: Insights From The Plato Trial 

      Franchi, Francesco; James, Stefan K.; Lakic, Tatevik Ghukasyan; Budaj, Andrzej J.; Cornel, Jan H.; Katus, Hugo A.; Keltai, Matyas; Kontny, Frederic; Lewis, Basil S.; Storey, Robert F.; Himmelmann, Anders; Wallentin, Lars; Angiolillo, Dominick J.; Parkhomenko, Alexander Nikolaevich; Oto, Ali; Skene, Allan; Budaj, Andrzej; Freij, Anneli; Santoso, Anwar; Armando; Lewis, Basil S.; Meier, Bernhard; Yu, Cheuk Man; Cannon, Christopher P.; Zambahari, Dato Seri Robaayah; Wu, Delon Wu; Ardissino, Diego; Raev, Dimitar; Kremastinos, Dimitrios; Weaver, Douglas; Paolasso, Ernesto; Giannitsis, Evangelos; Kontny, Frederic; Verheugt, Freek; Maurer, Gerald; Katus, Hugo; Emanuelsson, Hakan; Cornel, Jan H.; Horrow, Jay; Bassand, Jean-Pierre; Spinar, Jindrich; Morais, Joao; Lopez Sendon, Jose; Nicolau, Jose; Seung, Ki-Bae; Wallentin, Lars; Teik, Lim Soo; Heras, Magda; Claeys, Marc J.; Sabatine, Marc; Vintila, Marius; Keltai, Matyas; Ruda, Mikhail; Thorsen, Mona; Kleiman, Neil; Babilonia, Noe; Commerford, Patrick; Gurbel, Paul; Aylward, Phil; Steg, Philippe Gabriel; Theroux, Pierre; Sritara, Piyamitr; Pais, Prem; Becker, Richard; Lassila, Riitta; Harrington, Robert A.; Storey, Robert F.; Gao, Runlin; Husted, Steen; James, Stefan K.; Duris, Tibor; Chapichadze, Zaza; Investigators, PLATO (2019)
      Background-There are limited data on how the combination of diabetes mellitus (DM) and chronic kidney disease (CKD) affects cardiovascular outcomes as well as response to different P2Y(12) receptor antagonists, which ...